EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

Management Guidelines for Diabetic Patients With Hypertension

Weiqing Wang iD, Qin Wan, Suijun Wang, Guang Ning, Yufang Bi, Lianyong Liu, Yan Liu iD, Yu Liu iD, Xiaoying Li, Tingzhi Li, Xueyi Wu, Shengli Wu und 14 weitere

Journal of Diabetes · 2025-06 · 17 (6)

DOI: 10.1111/1753-0407.70093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 22.06.2025. Verfasst von Weiqing Wang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Diabetes Mellitus, Diabetes Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is one of the most common comorbidities associated with diabetes. The standardized diagnosis and treatment of hypertension in diabetic patients, along with achieving blood pressure targets, is of great significance for reducing long‐term complications, extending lifespan, and improving quality of life. Recent high‐quality multicenter large‐sample intervention studies have provided important evidence‐based grounds for setting blood pressure targets in diabetic patients. Therefore, based on a comprehensive summary of important domestic and international research literature, and in combination with clinical practice experience, this management guideline is now formulated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAntihypertensive AgentsDiabetes MellitusDiabetes ComplicationsHumansPractice Guidelines as TopicBlood Pressure

Stichwörter der Autor:innen

diabetes mellitushypertensionmedicationrisk factortarget

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Department of Endocrinology, Shanghai, China.
  • Department of Endocrinology, Punan Hospital of Pudong New District, Shanghai, China.
  • Department of Endocrinology, Third People's Hospital of Datong, Datong, China.
  • Department of Endocrinology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.

ORCID-Profile: Weiqing Wang, Yan Liu, Yu Liu, Yifei Zhang, Hongting Zheng, Yu Xu

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Wang, W., Wan, Q., Wang, S., Ning, G., Bi, Y., Liu, L., Liu, Y., Liu, Y., Li, X., Li, T., Wu, X., Wu, S., Sha, Y., Zhang, Y., Chen, R., Zheng, H., Zhao, D., Hu, L., Duan, P., …, & Pan, H. (2025). Management Guidelines for Diabetic Patients With Hypertension. Journal of Diabetes, 17(6). https://doi.org/10.1111/1753-0407.70093

Vancouver

Wang W, Wan Q, Wang S, Ning G, Bi Y, Liu L, et al. Management Guidelines for Diabetic Patients With Hypertension. Journal of Diabetes. 2025;17(6). doi:10.1111/1753-0407.70093

BibTeX
@article{Wang2025,
  author = {Wang, Weiqing and Wan, Qin and Wang, Suijun and Ning, Guang and Bi, Yufang and Liu, Lianyong and Liu, Yan and Liu, Yu and Li, Xiaoying and Li, Tingzhi and Wu, Xueyi and Wu, Shengli and Sha, Yubo and Zhang, Yifei and Chen, Rongyue and Zheng, Hongting and Zhao, Dong and Hu, Ling and Duan, Peng and Hou, Xinguo and Yuan, Guoyue and Xu, Yu and Huang, Shan and Kang, Zhiqiang and Dong, Qijuan and Pan, Huanfeng},
  title = {Management Guidelines for Diabetic Patients With Hypertension},
  journal = {Journal of Diabetes},
  year = {2025},
  volume = {17},
  number = {6},
  doi = {10.1111/1753-0407.70093}
}
Kostenlos starten →